Aequus Pharmaceuticals (AQS) News Today C$0.0050 -0.01 (-66.67%) (As of 05:21 PM ET) Add Share Share Headlines Stock AnalysisChartEarningsInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Aequus Pharmaceuticals Reports Revenue Growth Amid RestructuringNovember 9, 2024 | markets.businessinsider.comAequus Pharmaceuticals Inc. (AQSZF)September 5, 2024 | finance.yahoo.comAequus Pharmaceuticals Inc (AQS)August 3, 2024 | investing.comClosing Bell: Aequus Pharmaceuticals Inc down on Friday (AQS)July 23, 2024 | theglobeandmail.comAequus Pharmaceuticals Full Year 2023 Earnings: CA$0.022 loss per share (vs CA$0.024 loss in FY 2022)May 2, 2024 | finance.yahoo.comAQS:CA Aequus Pharmaceuticals Inc.April 20, 2024 | seekingalpha.comZoomd Technologies: Top 10 Undervalued Growth Stocks on TSX-V (ZOMD)February 23, 2024 | theglobeandmail.comAequus Pharmaceuticals: Top 10 Undervalued Drug Manufacturers Industry Stocks (AQS)February 18, 2024 | theglobeandmail.comAequus Pharmaceuticals Inc AQSDecember 12, 2023 | morningstar.comAequus Pharmaceuticals reports Q3 resultsNovember 30, 2023 | msn.comClosing Bell: Aequus Pharmaceuticals Inc up on Thursday (AQS)October 18, 2023 | theglobeandmail.comClosing Bell: Aequus Pharmaceuticals Inc flat on Thursday (AQS)October 7, 2023 | theglobeandmail.comClosing Bell: Aequus Pharmaceuticals Inc flat on Tuesday (AQS)October 5, 2023 | theglobeandmail.comClosing Bell: Aequus Pharmaceuticals Inc flat on Friday (AQS)September 29, 2023 | theglobeandmail.comClosing Bell: Aequus Pharmaceuticals Inc flat on Wednesday (AQS)September 29, 2023 | theglobeandmail.comAequus Pharmaceuticals: Aequus Reports Second Quarter 2023 Financial Highlights and General UpdateAugust 30, 2023 | finanznachrichten.deAequus Reports Second Quarter 2023 Financial Highlights and General UpdateAugust 29, 2023 | markets.businessinsider.comClosing Bell: Aequus Pharmaceuticals Inc up on Wednesday (AQS)August 25, 2023 | theglobeandmail.comAequus Announces Zimed PF Now Available in CanadaAugust 24, 2023 | finance.yahoo.comAequus Announces Zimed PF Website LaunchAugust 22, 2023 | finance.yahoo.comAequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in CanadaAugust 18, 2023 | finance.yahoo.comAequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%)July 6, 2023 | benzinga.comAQS.V - Aequus Pharmaceuticals Inc.June 7, 2023 | ca.finance.yahoo.comAequus Pharmaceuticals: Aequus Provides General Update and First Quarter 2023 Financial HighlightsMay 31, 2023 | finanznachrichten.deAequus Provides General Update and First Quarter 2023 Financial HighlightsMay 31, 2023 | finance.yahoo.comAequus Provides General Update and Fiscal 2022 Financial ResultsMay 2, 2023 | finance.yahoo.comAequus Grants Stock OptionsApril 19, 2023 | finance.yahoo.comAequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%) and Board UpdateApril 5, 2023 | finance.yahoo.comAequus Pharmaceuticals Inc. (AQS.V)March 26, 2023 | finance.yahoo.comAequus Announces Health Canada Notice of Compliance (NOC) for Zimed® Preservative Free (Bimatoprost 0.03%)December 20, 2022 | finance.yahoo.comAequus Pharmaceuticals Third Quarter 2022 Earnings: CA$0.004 loss per share (vs CA$0.003 loss in 3Q 2021)December 3, 2022 | yahoo.comAequus Pharmaceuticals: Aequus Reports Third Quarter 2022 Financial HighlightsNovember 30, 2022 | finanznachrichten.deAequus Reports Third Quarter 2022 Financial HighlightsNovember 30, 2022 | finance.yahoo.comAequus Announces Sandoz Contract Expiry at Year End and Expected Health Canada Approval for Zimed® PF (Preservative Free)November 29, 2022 | finance.yahoo.comAequus Pharmaceuticals IncOctober 9, 2022 | reuters.comAequus Pharmaceuticals reports Q2 resultsAugust 30, 2022 | seekingalpha.comAequus Reports Second Quarter 2022 Financial Highlights and General UpdateAugust 29, 2022 | finance.yahoo.comIIROC Trading Resumption - AQSJuly 13, 2022 | finance.yahoo.comAequus Resumes Trading on TSX Venture ExchangeJuly 13, 2022 | finance.yahoo.comAequus Provides General Update and Reports Record 2021 Financial ResultsJuly 1, 2022 | financialpost.comAequus Provides Update on Delay in Filing Annual Financial StatementsMay 7, 2022 | stockhouse.comIIROC Trading Halt - AQS.WTMay 2, 2022 | finance.yahoo.comIIROC Trading Halt - AQS.DBMay 2, 2022 | finance.yahoo.comAequus Announces Short Term LoanMay 2, 2022 | stockhouse.comAequus Announces Director ResignationApril 22, 2022 | benzinga.comSandoz and Aequus Agree to 1-Year Extension on Vistitan in CanadaJanuary 11, 2022 | finance.yahoo.comAequus Announces Canadian Filing of NDS for Preservative-Free Glaucoma MedicationJanuary 6, 2022 | finance.yahoo.comIs Aequus Pharmaceuticals (CVE:AQS) Weighed On By Its Debt Load?November 5, 2021 | ca.finance.yahoo.comAequus Reports Third Quarter 2021 Financial HighlightsNovember 3, 2021 | apnews.comAequus Reports Second Quarter 2021 Financial HighlightsAugust 30, 2021 | stockhouse.com Get Aequus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AQS and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin AQS Media Mentions By Week AQS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AQS News Sentiment▼0.000.46▲Average Medical News Sentiment AQS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AQS Articles This Week▼00▲AQS Articles Average Week Get Aequus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AQS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:AQS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aequus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aequus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AQS Stock Alerts